Ovid seeks to deliver medicines that provide meaningful improvements to the lives of people and families affected by epilepsies and brain disorders that present with seizures.
Our team is curious and persevering in our mission to serve patient communities. We strive to operate with the utmost integrity in every decision and action our company takes.
Ovid Therapeutics is a biopharmaceutical company striving to conquer epilepsies and seizures with courageous science. Today, nearly 50 million people across the world live with epilepsies and seizures. Approximately half these patients take five or more medicines, yet they still experience seizures. Additionally, some current anti-seizure medicines can also be hard to tolerate as they cause side effects that can diminish overall quality of life.